Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
The Effects of Folic Acid and Pyridoxine Supplementation on Characteristics of Migraine Attacks in Migraine Patients With Aura: A Double-Blind, Randomized Placebo-Controlled, Clinical Trial Publisher Pubmed



Askari G1 ; Nasiri M2 ; Mozaffarikhosravi H3 ; Rezaie M4 ; Bagheribidakhavidi M5 ; Sadeghi O6
Authors
Show Affiliations
Authors Affiliations
  1. 1. Food Security Research Center and Department of Community Nutrition, School of Nutrition and Food Science, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Department of Operating Room Technology, Paramedical School, Qom University of Medical Sciences, Qom, Iran
  3. 3. Department of Nutrition, School of Health, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
  4. 4. Department of Nursing, School of Nursing and Midwifery, Isfahan University of Medical Sciences, Isfahan, Iran
  5. 5. Department of Nutrition, School of Health, Kerman University of Medical Sciences, Kerman, Iran
  6. 6. Department of Community Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran

Source: Nutrition Published:2017


Abstract

Objective The aim of this study was to assess the effects of folic acid alone and in combination with pyridoxine on characteristics of migraine attacks in adult migraine patients with aura. Methods This double-blind, randomized placebo-controlled, clinical trial was conducted on 95 migraine patients with aura (age range 18–65 y) in Isfahan, Islamic Republic of Iran, in 2014. Patients were randomly allocated to receive folic acid (5 mg/d) plus pyridoxine (80 mg/d) or folic acid alone (5 mg/d) or placebo (lactose) for 3 mo. Characteristics of migraine attacks including headache severity, attacks frequency, duration, and headache diary results (HDRs) were obtained for each patient at baseline and at the end of the study. Results Folic acid plus pyridoxine intake resulted in a significant decrease compared with placebo in headache severity (−2.71 ± 0.08 versus −2.19 ± 0.05; P < 0.001), attack frequency (−3.35 ± 0.09 versus −2.73 ± 0.05; P < 0.001), duration (−7.25 ± 0.17 versus −6.5 ± 0.07; P < 0.001), and HDR (−74.15 ± 0.2 versus −72.73 ± 0.1; P < 0.001). Additionally, the reduction in these characteristics of migraine attacks in the folic acid plus pyridoxine group was significant compared with the group given folic acid alone (P < 0.001). However, these beneficial effects of the combined supplement became nonsignificant for attack duration compared with the folic acid–only and placebo groups after controlling for confounders. Folic acid intake without pyridoxine did not lead to a significant decrease in characteristics of migraine attacks compared with placebo group. Conclusions Supplementation of folic acid with pyridoxine could decrease the characteristics of migraine attacks including headache severity, attack frequency, and HDR; however, further studies are needed to shed light on the findings of the present study. © 2017 Elsevier Inc.
Other Related Docs
18. Vitamin D Status in Migraine Patients: A Case-Control Study, BioMed Research International (2014)
28. L-Carnitine Versus Propranolol for Pediatric Migraine Prophylaxis, Iranian Journal of Child Neurology (2021)